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Background and purpose — There is no consensus about the out-
come of simultaneous vs. staged bilateral total knee arthroplasty 
(TKA). We examined this issue by analyzing 238,373 patients.
Patients and methods — Demographic, clinical, and outcome 
data were evaluated for TKA patients (unilateral: 206,771; simul-
taneous bilateral: 6,349; staged bilateral: 25,253) from the Cana-
dian Hospital Morbidity Database for fi scal years 2006–2007 to 
2012–2013. Outcomes were adjusted for age, sex, comorbidities, 
and hospital TKA volume.
Results — Simultaneous bilateral TKA patients were younger 
than staged bilateral TKA patients (median 64 years vs. 66 years), 
were more likely to be male (41% vs. 39%), and had a lower fre-
quency of having > 1 comorbid condition (2.9% vs. 4.2%). They 
also had a higher frequency of blood transfusions (41% vs. 19%), 
a shorter  median  length of stay (6 days vs. 8 days), a higher fre-
quency of transfer to a rehabilitation facility (46% vs. 9%), and 
a lower frequency of  knee infection (0.5% vs. 0.9%) than staged 
bilateral TKA patients, but they had higher rate of cardiac com-
plications within 90 days (2.0% vs. 1.7%). Simultaneous patients 
had higher in-hospital mortality compared to the second TKA 
in staged patients (0.16% vs. 0.06%), but they had similar rates 
of in-hospital mortality compared to unilateral patients (0.16% 
vs. 0.14%). The cumulative 3-year revision rate was highest in 
the unilateral group (2.3%), but it was similar in the staged and 
simultaneous bilateral groups (1.4%).
Interpretation — We found important differences between the 
outcomes of simultaneous and staged bilateral TKA. Further clar-
ifi cation of outcomes would be best determined in an adequately 
powered randomized trial, which would remove the selection bias 
inherent in this retrospective study design.
■
Patients who have bilateral knee arthritis and are candidates 
for total knee arthroplasty (TKA) may decide between simul-
taneous or staged bilateral TKA (BTKA). Confl icting out-
comes have been reported for simultaneous and staged BTKA. 
Simultaneous BTKA has advantages that include bilateral 
functional recovery with only a single operation, anesthetic, 
hospitalization, recovery period, and analgesia regimen. It 
may also lead to better improvements in quality-adjusted life 
years, lower costs, and better outcomes (Fu et al. 2013, Odum 
et al. 2013). However, several meta-analyses have shown that 
simultaneous bilateral TKA may be associated with increased 
risks of cardiac complications (Restrepo et al. 2007), pul-
monary embolism (Restrepo et al. 2007, Fu et al. 2013), and 
death (Restrepo et al. 2007, Hu et al. 2011, Fu et al. 2013) than 
staged bilateral TKA. In contrast, other studies have shown 
that complications may be more frequent with staged BTKA 
than with simultaneous BTKA (Memtsoudis et al. 2009), but 
90-day mortality may be similar between unilateral TKA 
and simultaneous and staged BTKA (Walmsley et al. 2006). 
In addition, it may be diffi cult to compare simultaneous and 
staged BTKA because many patients (37% in one study) may 
not undergo the second stage of BTKA due to dissatisfaction 
with the fi rst operation, unmet expectations, complications, or 
death (Sesen et al. 2015). 
In Canada (with 35 million inhabitants), TKA is the most 
common type of joint replacement surgery, with 45,830 TKAs 
in 2012–2013 that accounted for 57,718 acute-care hospital-
izations (Canadian Institute for Health Information 2014). We 
compared early outcomes of unilateral TKA, simultaneous 
BTKA, and staged BTKA using a large Canadian data set, 
including complications, in-hospital mortality, length of hos-
pital stay, discharge disposition, and revision risk.
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Patients and methods
The study cohort was selected from the Canadian Hospital 
Morbidity Database (HMDB) and contained all the patients 
who were discharged after primary TKA between April 2006 
(fi scal year 2006–2007) and March 2013 (fi scal year 2012–
2013). The HMDB is a national data holding managed by the 
Canadian Institute for Health Information (CIHI) that cap-
tures administrative, clinical, and demographic information 
on inpatient discharge or transfer from all acute-care hospi-
tals. Primary TKA records were identifi ed using the Canadian 
Classifi cation of Health Interventions (CCI) codes 1.VG53.
LA.PN.^ and 1.VG53.LA.PP.^ with status attribute primary 
and extent attribute bicompartmental or tricompartmen-
tal (Canadian Institute for Health Information, 2015a). The 
cohort was subdivided into 3 groups: (1) simultaneous BTKA 
(i.e. both TKAs were performed on the same day); (2) staged 
BTKA (i.e. both knees were replaced in 2 separate opera-
tions within a year); and (3) unilateral TKA (i.e. only 1 TKA 
was performed within a year). For staged BTKA, the 1-year 
cutoff was selected because patients who had the second-
stage TKA performed within 1 year probably had suffi cient 
bilateral symptoms to initially consider having simultaneous 
BTKA (Stefánsdóttir et al. 2008). We excluded unilateral 
TKA patients who could have been considered to be staged 
BTKA patients because they underwent a contralateral TKA 
within 12 months in either the year prior to or the year follow-
ing the study period.
Explanatory variables of interest included patient age, sex, 
comorbidities, and hospital TKA volume quartiles. Comorbid-
ities were defi ned using the Charlson comorbidity index (Quan 
et al. 2005) (Appendix Table A, see Supplementary data) and 
grouped by patients who had  at least 1 predefi ned comorbid 
condition (index > 0) or no predefi ned comorbid conditions 
(index = 0). Characteristics and outcomes compared between 
the groups included blood transfusion during the hospitaliza-
tion, length of stay in the acute-care facility, complications, 
discharge disposition, cumulative percentage revised during 
each of the 3 years following the index surgery, and inpatient 
mortality. To control for the possible confounding effects of 
length of stay, complications were determined by combining 
inpatient and outpatient complications. Inpatient complica-
tions were defi ned as complications that presented during the 
same hospitalization as the TKA, and included cardiac events 
(acute cardiac ischemia, infarction, and arrhythmia), pulmo-
nary embolism, and infection of the TKA (Appendix Table 
B, see Supplementary data). Outpatient complications were 
defi ned in the same fashion, and were captured if a patient 
was re-admitted to an acute-care hospital (including being 
transferred back from a rehabilitation facility where acute 
complications are usually not managed) for treatment of any 
of these within 90 days of discharge. The 3-year follow-up 
data for revision rates were not available for patients who had 
revision TKA outside the years included. Due to coding dif-
ferences, data on pulmonary embolism and re-admission were 
not included for patients who were discharged before March 
31, 2009. Revision procedures were identifi ed using CCI 
codes (1.VG.53 and 1.VP.53) and the status attribute revision. 
Except where noted otherwise, outcomes were calculated per 
patient (not per operation) to enable patient-specifi c compari-
son of complication risk in simultaneous BTKA with cumula-
tive complication risk at both stages of staged BTKA. Thus, 
outcomes were reported if they occurred at least once after 
each TKA of staged bilateral patients. For discharge disposi-
tion, “home setting” might include a seniors’ lodge, supportive 
housing, or assistance with meals and/or housekeeping. The 
cumulative risk of mortality for either the fi rst or second stage 
of staged BTKA could not be accurately estimated because 
information on whether an operation was planned as staged 
was not available for patients who were intended for staged 
BTKA but who died after their fi rst TKA was performed. Thus, 
mortality of patients who died after the fi rst stage and before 
the second stage of a planned staged surgery was included in 
the unilateral TKA group.
Statistics
Data analysis was performed with SAS software version 9.2. 
Categorical variables were compared using chi-square test, 
and continuous variables were compared using t-test (means) 
and Mann-Whitney U test (medians). The p-values that are 
reported for outcomes included adjustment for age, sex, pre-
operative comorbidities, and hospital TKA volume, using 
linear regression for continuous outcomes, logistic regression 
for binary outcomes, and multinomial logistic regression for 
categorical outcomes. The level of signifi cance was set at 0.05 
for all tests.
Ethics
The CIHI did not require ethical approval for this analysis of 
its data holdings. Data sharing agreements with each Canadian 
province, privacy protection mechanisms, and analytical rules 
ensure that no individual patient information is identifi able.
Results
During the 7 years of the study, most TKAs performed were 
unilateral, and the ratio of simultaneous to staged BTKA was 
1:4 (Table 1). Most staged BTKAs (94%) were performed 
with at least 3 months between stages. From 2006–2007 to 
2012–2013, the annual number of unilateral TKAs increased 
by 39% to 37,994, simultaneous BTKAs decreased by 8% to 
954, and staged BTKAs increased by 28% to 4,505.
Simultaneous BTKA patients were younger, more often 
male, and had a lower frequency of comorbidity than patients 
who underwent staged bilateral TKA or unilateral TKA. 
Compared to staged bilateral and unilateral TKA, simultane-
ous BTKAs were more frequently performed in hospitals that 
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were in the highest quartile of TKA volume. Simultaneous 
BTKA patients had shorter median inpatient length of stay 
than staged BTKA patients, and a different profi le of dis-
charge disposition. Simultaneous BTKA patients were more 
frequently discharged to a rehabilitation facility than staged 
BTKA patients, and most patients who had staged BTKA 
(88.2%) were discharged to home or to a home setting (Table 
1). 
Simultaneous BTKA patients generally had higher rates of 
blood transfusion and cardiac complications compared to the 
other groups, a higher pulmonary embolism rate than the uni-
lateral group, and a lower frequency of knee infection than 
staged patients. We could not detect any difference in in-hos-
pital mortality between the simultaneous BTKA group and the 
unilateral TKA group. While the staged group had the lowest 
in-hospital mortality rate, it underestimated the true mortality 
risk, since it did not include staged patients who died after 
their fi rst TKA. The unilateral group had the highest revision 
risk at 3 years (Table 2).
Male sex, age > 75 years, and the presence of at least 1 
Charlson-based comorbidity all tended to increase the odds 
of cardiac complication, pulmonary embolism, knee infec-
tion, and in-hospital mortality. Lower TKA volume of a facil-
ity appeared to have a protective effect regarding pulmonary 
embolism, but it had no clear effect on cardiac complication or 
infection (Tables 3 and 4).
 
Discussion
Over the 7-year period from April 2006 to March 2013, the 
volume of simultaneous BTKAs in Canada dropped, while 
the volume of unilateral TKA and staged bilateral TKA both 
increased.  This trend may in part be explained by concerns 
regarding increased mortality risk in patients undergoing 
simultaneous BTKA (Stefánsdóttir et al. 2008), which is 
also refl ected by the selection bias of younger age and fewer 
comorbidities in this group.   
The observation that patients were older in the staged BTKA 
group than in the simultaneous BTKA group (Table 1) is con-
sistent with the results of previous studies (Stefánsdóttir et al. 
2008, Odum et al. 2013). Surgeons may offer simultaneous 
procedures to younger and healthier patients, thus creating a 
selection bias and possibly contributing to better outcomes for 
simultaneous BTKA than would otherwise be observed. The 
greater proportion of male patients in the simultaneous BTKA 
group than in the staged BTKA group (Table 1) is similar to 
observations made in several previous studies (Ritter et al. 
2003, Barrett et al. 2006, Hutchinson et al. 2006, Stefánsdóttir 
et al. 2008, Fu et al. 2013, Odum et al. 2013).
The fi ndings that after simultaneous BTKA, patients had a 
higher frequency of discharge to a rehabilitation facility and 
a lower frequency of discharge to home than staged BTKA 
patients are consistent with those in other studies; however, 
Table 1. Patient demographics and hospital stay characteristics a
  Bilateral b  
Characteristic Unilateral b Simultaneous b 1st stage  2nd stage p- value c
No. of patients 206,771 6,349  25,253  
No. of replacements  229,050 6,349  25,253   
Median age (interquartile range) 68 (61–75) 64 (58–71) 66 (60–73)  67 (60–74) < 0.001
Sex, male (%) 39 41  39  0.01
Comorbidity present (%) 5.09 2.87 4.23  4.39 < 0.001
Percentage of operations, by hospital TKA volume        
 1st quartile (lowest volume)  6 2  5 
 2nd quartile 15 7  14  < 0.001
 3rd quartile 27 21  26  
 4th quartile (highest volume) 52 70  55  
Median total inpatient length of stay (d) d 4 6  8  < 0.001
Discharge disposition (%) e         
 Transfer to acute care  2.6 2.9  2.1  
 Transfer to general/special rehabilitation 10.1 46  8.7  
  Transfer to chronic care facility 1.2 2.3  0.9  < 0.001
  Home or home setting with support services 32.3 22  32  
  Home without support services 53.8 27  56  
  Other 0.1 0.2  0.1  
a n = 238,373 patients. Source: Hospital Morbidity Database, Canadian Institute for Health Information, 2006–2007 to 2012–2013. 
b Unilateral: 1 knee replaced within 1 year; simultaneous bilateral: both knees replaced during the same operation; staged bilateral: both knees 
replaced in separate operations within 1 year.
c Comparison between bilateral TKA groups (simultaneous vs. staged [completed], unless otherwise specifi ed), after adjusting for patient age 
at surgery, sex, Charlson-based comorbidity, and TKA volume of facility. Statistical signifi cance was defi ned by p < 0.05.
d For staged bilateral TKA, the  total inpatient length of hospital stay was the sum for both stages, calculated for each patient. Median hospital-
ization per hospital stay was 4 days/hospitalization.
e Staged bilateral TKA: only the discharge disposition after the second stage was used. The data exclude patients who died during their hospi-
tal stay.
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previous studies found that more than one-third of 
simultaneous BTKA patients were discharged to inpa-
tient rehabilitation (Lombardi et al. 2001, Bullock et al. 
2003, Cushner et al. 2005).
The more than doubled transfusion rate with simul-
taneous BTKA than with staged BTKA (Table 2) may 
have resulted from greater blood loss from the bilat-
eral bone cuts and surgical trauma with simultaneous 
Table 2. Transfusion, complications, in-hospital mortality, and revision risk following unilateral and bilateral TKA
Outcome Unilateral TKA  Bilateral TKA  p-value a p-value b              
   Simultaneous  Staged Sim. vs. Staged Sim. vs. Unilat
Blood transfusion (% of patients) 13.3 41 18.6 c < 0.001 < 0.001
Inpatient complication rate (% of patients) d
 Cardiac complications  1.3 1.8 1.7 c 0.1 < 0.001
 Pulmonary embolism  0.7 1.1 0.8 c 0.1 0.004
 Knee infection  0.06 N/R g 0.04 c – e – e
   (< 0.14% but 
   > 0.06%, n < 5)   
Outpatient complication rate (% of patients)  (defi ned as 90-day re-admission for treatment of same) d
 Cardiac complications  0.05 N/R g 0.04 c – e – e
   (< 0.14% but 
   > 0.05%, n < 5)   
 Pulmonary embolism  0.14 0.23 0.13 c – e 0.2
 Knee Infection  0.6 0.4 0.8 c 0.02 0.2
Overall complication rate (inpatient plus outpatient)f (% of patients) d
 Cardiac complications  1.4 2.0 1.7 c 0.04 < 0.001
 Pulmonary embolism  0.8 1.2 0.9 c 0.12 0.01
 Knee infection  0.7 0.5 0.9 c 0.02 0.3
In-hospital mortality (%) h 0.14 0.16 0.06 0.005 0.2
Cumulative revision rate (%) i
 Year 1 1.07 0.68 0.63 0.6 < 0.001
 Year 2 1.84 1.00 0.96 0.8 < 0.001
 Year 3 2.34 1.41 1.37 0.9 < 0.001
a Comparison between bilateral TKA groups (simultaneous vs. staged). p-value after adjusting for patient age at time of surgery, 
sex, Charlson-based comorbidity, and TKA volume of facility. Signifi cance level set at 0.05. 
b Comparison between bilateral TKA groups (simultaneous vs. unilateral). p-value after adjusting for patient age at time of sur-
gery, sex, Charlson-based comorbidity, and TKA volume of facility. Signifi cance level set at 0.05. 
c  Outcomes could be at one or both stages, but they were counted if present at least once. 
d Patients discharged before 2009–2010 were excluded due to coding differences (diagnosis cluster was not available).
e p-value not reported due to a possible bias in the logistic regression model estimates arising from the relative rarity of the 
observed event.
f If a patient experienced a complication event (cardiac, PE, or infection) in hospital and/or was re-admitted with it within 90 days, 
one combined event was coded. 
g N/R: not reportable. In accordance with the CIHI privacy policy, cells with counts of 1–4 were suppressed. Suppressed cells 
were included in the totals. 
h Mortality during hospitalization for TKA. Patients who had planned staged bilateral TKA but had died after the fi rst stage and 
before the second stage were included with mortality data for unilateral TKA.
i Does not include patients who had revision outside of the years included.
Table 3. Logistic regression model for combined complication risk (inpatient plus outpatient)
  Cardiac complication Pulmonary embolism Knee infection
Variable Odds ratio 95%CI p-value Odds ratio 95%CI p-value Odds ratio 95%CI p-value
Group (simultaneous BTKA vs. unilateral TKA) 1.7 1.4–2.2 < 0.001 1.5 1.1–2.0 0.01 0.8 0.5–1.2 0.3
Sex (male vs. female) 1.3 1.2–1.4 < 0.001 0.8 0.7–0.9 < 0.001 1.6 1.4–1.9 < 0.001
Age group (> 75 vs. < 75) 2.4 2.2–2.6 < 0.001 1.4 1.2–1.6 < 0.001 1.0 0.9–1.2 0.6
Charlson-based comorbidity present (yes vs. no) 3.4 3.0–3.8 < 0.001 1.9 1.5–2.3 < 0.001 1.9 1.5–2.3 < 0.001
TKA volume of facility (quartile 1 vs. quartile 4) 0.8 0.7–1.0 0.1 0.6 0.4–0.8 < 0.001 1.0 0.7–1.3 0.9
 
Table 4. Multiple logistic regression model for in-hospital mortality risk
  In-hospital mortality
Variable Odds ratio 95%CI p-value
Group (simultaneous vs. unilateral) 1.5 0.8–2.9 0.2
Sex (male vs. female) 1.9 1.5–2.4 < 0.001
Age group (> 75 vs. < 75) 3.6 2.9–4.5 < 0.001
Charlson-based comorbidity present (yes vs. no) 7.8 6.2–9.8 < 0.001
TKA volume of facility (quartile 1 vs. quartile 4) 0.7 0.4–1.2 1.00
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BTKA, which is consistent with the previous observation of 
lower blood loss after staged BTKA than after simultaneous 
BTKA (Forster et al. 2006). In staged BTKA, a suffi cient 
interval between stages may enable hematopoiesis to replen-
ish blood loss from the fi rst surgery (Fu et al. 2013). In our 
study, > 90% of staged patients waited more than 3 months 
between procedures, probably allowing normalization of 
hemoglobin before the second procedure. There were no data 
available about the volume of blood transfused, but previous 
studies have shown a greater likelihood and greater volume of 
blood transfusion with simultaneous BTKA than with staged 
BTKA (Lombardi et al. 2001, Bullock et al. 2003, Yoon et 
al. 2010). However, these results should be interpreted with 
caution because blood transfusion practices and reporting 
may vary between hospitals and between surgeons (Patil and 
Wakankar 2008, Fu et al. 2013).  
The cardiac complication rate and pulmonary embolism rate 
were highest in the simultaneous bilateral group than in the 
other 2 groups, with the exception of the comparison between 
pulmonary embolism rates in the simultaneous and staged 
groups, which did not reach statistical signifi cance (p = 0.1). 
These differences are generally consistent with some meta-
analyses that have shown higher risks of cardiac complications 
(Restrepo et al. 2007) and pulmonary embolism (Restrepo et 
al. 2007, Fu et al. 2013) in simultaneous BTKA than in staged 
BTKA. However, the literature is equivocal, with 3 large 
meta-analyses not fi nding evidence for increased cardiac risk 
(Hu et al. 2011, Fu et al. 2013, Hussain et al. 2013), and 2 
not fi nding an increased risk of pulmonary embolism (Hu et 
al. 2011, Hussain et al. 2013). The reasons for these differ-
ences are unclear, but there was a lack of consistency in either 
selection of the control group (staged bilateral vs. unilateral) 
and/or in controlling for possible confounding factors (such as 
age, sex, length of stay, and comorbidities) in both the meta-
analyses and the studies they included in their analysis.   
The lower frequency of knee infections in the simultane-
ous BTKA group than in the staged BTKA group (Table 2) is 
consistent with results of previous studies (Ritter et al. 1997, 
Meehan et al. 2011, Fu et al. 2013). In contrast, other stud-
ies have not shown any difference in the frequency of super-
fi cial infection (Yoon et al. 2010, Fu et al. 2013). However, a 
case-control study involving 72 bilateral simultaneous TKA 
patients matched to 144 unilateral TKA patients, based on 
age and sex, showed a greater frequency of superfi cial and 
deep infection after simultaneous BTKA than after unilateral 
TKA with a minimum of 6 months follow-up. The authors 
suggested that contributory factors may have included longer 
operating time, more personnel in the operating room, and 
rescrubbing, redraping, and changing of instruments between 
the simultaneous procedures (Luscombe et al. 2009).  
We found a lower revision rate in the simultaneous BTKA 
group than in the unilateral TKA group, but we did not detect 
a difference in revision rates between the 2 BTKA groups. 
A previous meta-analysis and population-based study found 
that simultaneous procedures were associated with a lower 
frequency of revision in simultaneous BTKA than in staged 
BTKA (Meehan et al. 2011, Fu et al. 2013). However, 4 
smaller studies showed no difference in the frequency of 
revision between patients who had simultaneous BTKA and 
those who had staged BTKA, which is similar to our fi ndings 
(Table 2) (Leonard et al. 2003, Ritter et al. 2003, Hutchin-
son et al. 2006, Taylor et al. 2010).  Kreder et al. (2003) have 
found higher revision risk to be associated with lower volume 
facilities.  The higher revision risk in our unilateral group may 
simply refl ect the fact that a larger proportion of these cases 
were performed in lower volume facilities. or simply that 
patients who had intended to undergo staged TKA but under-
went early revision of the fi rst side and declined the contralat-
eral procedure were captured in the unilateral group.
A clear understanding of true differences in mortality risk 
between the 3 groups (unilateral TKA, staged BTKA, and 
simultaneous BTKA) is diffi cult to gain from the literature. 
There have been no adequately powered prospective studies, 
and the remaining literature consists of either large retrospec-
tive studies that were subject to the same types of selection 
bias as our work, inadequately powered small prospective 
series, or meta-analyses that incorporated these imperfect 
studies. Several recent meta-analyses (Restrepo et al. 2007, 
Hu et al. 2011, Fu et al. 2013) and large retrospective series 
(Memtsoudis et al. 2008, 2009, Stefánsdóttir et al. 2008) 
have shown increased in-hospital and 30-day mortality risk 
in simultaneous BTKA patients, but some were limited by the 
use of only a unilateral TKA comparison group (Restrepo et 
al. 2007, Memtsoudis et al. 2008, 2009), or did not adjust for 
the confounding effect of comorbidities (Stefánsdóttir et al. 
2008). Other meta-analyses are consistent with the results of 
the present study, and found no increased risk of in-hospital 
mortality in the simultaneous BTKA group (Hussain et al. 
2013). The only large case series that attempted to control for 
the effect of planned staged BTKA patients who did not pro-
ceed to the second side found that there was no increased mor-
tality risk in the simultaneous BTKA group than in the staged 
BTKA group (Meehan et al. 2011). While our fi ndings do not 
resolve this controversy, we have found similar in-hospital 
mortality rates and risk in patients undergoing unilateral TKA 
and simultaneous BTKA—similarities that remained when we 
adjusted for age, sex, comorbidities, and hospital volume. This 
may also refl ect the marked decrease in mortality rates in elec-
tive TKA patients that has occurred since the 1990s (Lalmo-
hamed et al. 2014). We feel that the statistically signifi cantly 
lower mortality rate in the staged group may have been the 
result of selection bias in those who proceeded with TKA sur-
gery on the second side, and it should therefore be interpreted 
with caution.
The limitations of our study included the absence of infor-
mation about patients who had intended to have staged BTKA 
but deferred the second side. In-hospital mortality in the 
staged BTKA group was underestimated, and in the unilat-
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eral group it was probably overestimated because patients 
who died after the fi rst stage and before the second stage were 
excluded from the staged group and included in the unilateral 
group by default. Similarly, the complications and revisions 
of those patients who declined to proceed with the planned 
second TKA would have been included in the unilateral group, 
thus leading to overestimation of these risks in the unilateral 
group and to underestimation in the staged group. Mortality 
data were limited to in-hospital deaths, and early postopera-
tive mortality may have been underestimated because of the 
typically brief postoperative length of hospital stay (median 
4–6 days). In addition, the study may have underestimated 
the frequency of patients who had comorbidities; the low fre-
quency of patients who had Charlson comorbidity index > 1 
(Table 1) may have occurred because several common and 
important medical conditions such as diabetes (without com-
plications), previous myocardial infarction, and peripheral 
vascular disease had a weight factor of 0 in the index (Table A, 
see Supplementary data). However, changing of the 0 weight 
factors to 1 for these conditions and re-running the analysis 
did not change our fi ndings (data not shown). Another con-
cern may be that a comorbidity is detected only after admis-
sion to hospital; however, pre-admission clinics that screen 
the patient’s fi tness for surgery are ubiquitous across Canada, 
and it would be very unusual for a patient to undergo elec-
tive surgery without a clinically relevant comorbidity being 
identifi ed prior to admission. We also recognize that it was not 
possible to adjust for possible confounding factors that were 
not captured in our data set, such as body mass index, physical 
fi tness, or others. Furthermore, comparison of perioperative 
care between patient groups was not possible because these 
data were not available.
Miscoding is a potential source of error in administrative 
databases, but CIHI has a comprehensive data quality pro-
gram that involves a continuous process of data improvement 
(Canadian Institute for Health Information, 2009 and 2015b). 
While there are no published data on the accuracy of coding of 
total knee replacements, an assessment of coding for hip frac-
ture admissions revealed a positive predictive value (PPV) of 
97% (Canadian Institute for Health Information, 2010). This 
same data quality assessment found that diagnosis of a post-
admission acute myocardial infarction had a PPV of 82%, and 
that diagnosis of a post-admission deep venous thrombosis or 
pulmonary embolism had a PPV of 84%. Coding of comorbid-
ity level also appeared good, with an overall agreement rate 
of 90%. The reported sensitivities of capturing an in-hospital 
acute myocardial infarction (68%) and deep venous thrombo-
sis (66%) are lower; however, we have no reason to believe 
that there would be any systemic bias in the capture rates 
between the 3 groups (Canadian Institute for Health Infor-
mation, 2010). Another concern might be an artifi cially low 
acute-care hospital length of stay in the simultaneous BTKA 
group due to a planned transfer to a rehabilitation facility; 
however, the availability of rehabilitation beds in Canada is 
not always predictable and is therefore unlikely to have artifi -
cially reduced the length of stay. 
In summary, our study has shown important differences 
between outcomes of simultaneous BTKA and staged BTKA, 
with simultaneous BTKA having a higher frequency of 
blood transfusion, a lower median hospital length of stay, a 
higher proportion of discharge to a rehabilitation facility, a 
lower 90-day risk of knee infection, and higher 90-day risk 
of cardiac complication. Simultaneous BTKA patients appear 
to have similar rates of in-hospital mortality compared to 
patients undergoing unilateral TKA, but a lower risk of revi-
sion at 3 years. Generally speaking, patients having simultane-
ous BTKA were younger, were more often male, had a lower 
frequency of preoperative comorbidities, and more often had 
surgery in a high-volume center than patients having staged 
BTKA, which possibly contributed to selection bias in this 
study. Further investigation of outcomes would best be done 
in an adequately powered randomized trial.
Supplementary data
Tables A and B are available on the Acta Orthopaedica web-
site at www.actaorthop.org, identifi cation number 9269.
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